James Investment Research’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$690K	Buy	17,122 +24	+0.1%	+$897	0.08%	216
2025 Q4	$595K	Hold	17,098	–	–	0.07%	226
2025 Q3	$1.42M	Buy	17,098 +2,578	+18%	+$187K	0.16%	129
2025 Q2	$1.07M	Hold	14,520	–	–	0.13%	145
2025 Q1	$1.66M	Sell	14,520 -3,629	-20%	-$221K	0.21%	108
2024 Q4	$915K	Hold	18,149	–	–	0.11%	158
2024 Q3	$840K	Hold	18,149	–	–	0.1%	174
2024 Q2	$590K	Sell	18,149 -6	-0%	-$164	0.07%	199
2024 Q1	$457K	Sell	18,155 -10	-0.1%	-$236	0.05%	223
2023 Q4	$590K	Hold	18,165	–	–	0.07%	191
2023 Q3	$495K	Hold	18,165	–	–	0.07%	192
2023 Q2	$404K	Hold	18,165	–	–	0.05%	203
2023 Q1	$393K	Buy	18,165 +5,820	+47%	+$128K	0.05%	209
2022 Q4	$251K	Buy	12,345 +4,294	+53%	+$108K	0.04%	238
2022 Q3	$206K	Hold	8,051	–	–	0.03%	257
2022 Q2	$191K	Buy	+8,051	New	+$175K	0.03%	260
2017 Q4	–	Sell	-117,400	Closed	-$2.27M	–	783
2017 Q3	$2.27M	Buy	+117,400	New	+$1.75M	0.08%	212